Food News and Research

RSS

Swissmedic grants marketing authorization for Amitiza

Sucampo Pharma Europe Ltd., a subsidiary of Sucampo Pharmaceuticals, Inc., today announced that Swissmedic, the Swiss Agency for Therapeutic Products, has granted a marketing authorization for Amitiza® (lubiprostone) 24 microgram (mcg) gel capsules for the long-term treatment of patients with chronic idiopathic constipation (CIC).

20 Nov 2009

Data from second positive pivotal study of PSD502 for treatment of PE presented

At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora")., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE).

20 Nov 2009

Scientists identify and characterize different antioxidant compounds from foods

Scientists at the University of Granada have identified and characterized for the first time different antioxidant compounds from foods such as olive oil, honey, walnuts and a medicinal herb called Teucrium polium.

20 Nov 2009

2009 Report Card, an overall assessment of efforts to reduce lung cancer's mortality released

Today, Lung Cancer Alliance (LCA) released its annual National Report Card on Lung Cancer, an overall assessment of efforts to reduce lung cancer's mortality.

20 Nov 2009

Cigarettes are widely contaminated with bacteria, reveals study

Cigarettes are "widely contaminated" with bacteria, including some known to cause disease in people, concludes a new international study conducted by a University of Maryland environmental health researcher and microbial ecologists at the Ecole Centrale de Lyon in France.

19 Nov 2009

CWRU School of Medicine receives grant to fund a Public Health Practice Based Research Network

Case Western Reserve University (CWRU) School of Medicine (SOM) has received a Robert Wood Johnson grant to fund a Public Health Practice Based Research Network called The Ohio Research Association for Public Health Improvement (RAPHI).

19 Nov 2009

American Diabetes Association launches redesigned diabetes website

To meet the changing needs of people affected by this growing epidemic, the American Diabetes Association has launched a completely redesigned www.diabetes.org in English and Spanish. Even though diabetes is a growing epidemic, a recent survey conducted by the Association showed that Americans received a failing grade in diabetes awareness.

19 Nov 2009

World Summit on Food Security wraps up

The U.N. World Summit on Food Security ended Wednesday in Rome with Food and Agriculture Organization (FAO) head Jacques Diouf calling for the global community to shift the fight against global hunger from "words to action," Agence France-Press reports. Diouf said, "We must do this to have a more prosperous world, fairer, more equitable and more peaceful. But above all we must do this fast: the poor and starving can not wait" (11/18).

19 Nov 2009

MONITORING FORCE files for Flibanserin orphan drug status designation with the EMEA

MONITORING FORCE GmbH announced that they have filed on November 16th, 2009 Flibanserin in the indication treatment-relevant levodopa-induced dyskinesia in Parkinson's disease for orphan drug status designation with the European Medicines Agency (EMEA). Levodopa-induced dyskinesia is a complication of the mainstay treatment in advanced Parkinson's and a serious burden to some of those affected, since it may be disabling for the patients and preventing them from receiving optimal treatment for Parkinson's.

19 Nov 2009

Advanced Cell Technology files an IND with the FDA for study using embryonic stem cells to treat SMD

Advanced Cell Technology, Inc. announced today that it filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt’s Macular Dystrophy (SMD). Among the most common causes of untreatable blindness in the world are degenerative diseases of the retina.

19 Nov 2009

Positive results from Sciele Pharma's second pivotal study of PSD502 for the treatment of PE

At the annual meeting of the Sexual Medicine Society of North America, Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company, and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC, today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE).

19 Nov 2009

Fruitful and delicious recipes for holiday season

Mott's is getting sneaky this holiday season by teaming up with The Sneaky Chef, Missy Chase Lapine, to sneak Mott's into classic holiday meals. As many Americans tend to skimp on fruits and vegetables during this time of year, Mott's and The Sneaky Chef have responded with a list of holiday recipes that provide fruitful and delicious meals for both kids and adults to enjoy.

19 Nov 2009

DxNA announces successfull evaluation of its GeneSTAT PCR system

DxNA, a molecular diagnostics company headquartered in St. George, Utah, announced today that the DxNA GeneSTAT PCR system has successfully completed evaluation studies under the direction of a California laboratory supported by the Joint FAO/IAEA Programme in Food and Agriculture.

19 Nov 2009

Medtronic introduces imaging and visualization service for endovascular specialists

Continuing to drive innovation in endovascular aortic repair (EVAR), Medtronic, Inc., today announced the introduction of an imaging and visualization service for endovascular specialists who use the company’s market-leading portfolio of stent grafts to treat aortic aneurysms. Aortic aneurysms affect more than one million people in the United States alone and can rupture with fatal consequences if left untreated.

19 Nov 2009

Updated clinical guidelines on Effient treatment for ACS patients

Effient® (prasugrel) tablets, a new antiplatelet medicine, was added as a treatment option in two clinical guideline updates: one for patients receiving percutaneous coronary intervention (PCI) and a second one for patients with ST elevation myocardial infarction (STEMI), or severe heart attack.

19 Nov 2009

New online tool launched to encourage donations and fight global hunger

Mercy Corps is challenging Americans to put the "giving" back in Thanksgiving by matching the amount they spend on a meal this Thanksgiving Day with a donation that fights global hunger.

19 Nov 2009

Preliminary report from Harvard School of Public Health reveals students prefer healthy school meals

Think your kids won't eat healthy foods? Think again. A preliminary report of the Chefs in Schools Initiative by the Harvard School of Public Health, funded by Project Bread, proves that kids not only like healthy school meals, but actually eat more of the healthy foods than they would if they were eating a traditional school meal.

19 Nov 2009

FDA Advisory Committee votes in support of Pfizer's Prevnar 13

Pfizer Inc announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee voted 10 to 1 that the data presented support the safety and effectiveness of its 13-valent pneumococcal conjugate candidate vaccine, Prevnar 13™ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), for the prevention of invasive pneumococcal disease in infants and young children.

19 Nov 2009

FDA: Plavix-Prilosec combination may reduce anti-clotting effect

Patients should avoid using the stomach acid reducer Prilosec/Prilosec OTC (omeprazole) with the anti-clotting drug Plavix (clopidogrel), the U.S. Food and Drug Administration warned on Nov. 17.

19 Nov 2009

FDA issues complete response for Rituxan, a drug for treating chronic lymphocytic leukemia

Genentech, Inc., a wholly-owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), and Biogen Idec announced today that the U.S. Food and Drug Administration (FDA) issued a complete response on the companies’ applications for Rituxan® (rituximab) plus fludarabine and cyclophosphamide (FC) for the treatment of people with previously untreated and previously treated chronic lymphocytic leukemia (CLL).

19 Nov 2009

Food News and Research

Swissmedic grants marketing authorization for Amitiza

Data from second positive pivotal study of PSD502 for treatment of PE presented

Scientists identify and characterize different antioxidant compounds from foods

2009 Report Card, an overall assessment of efforts to reduce lung cancer's mortality released

Cigarettes are widely contaminated with bacteria, reveals study

CWRU School of Medicine receives grant to fund a Public Health Practice Based Research Network

American Diabetes Association launches redesigned diabetes website

World Summit on Food Security wraps up

MONITORING FORCE files for Flibanserin orphan drug status designation with the EMEA

Advanced Cell Technology files an IND with the FDA for study using embryonic stem cells to treat SMD

Positive results from Sciele Pharma's second pivotal study of PSD502 for the treatment of PE

Fruitful and delicious recipes for holiday season

DxNA announces successfull evaluation of its GeneSTAT PCR system

Medtronic introduces imaging and visualization service for endovascular specialists

Updated clinical guidelines on Effient treatment for ACS patients

New online tool launched to encourage donations and fight global hunger

Preliminary report from Harvard School of Public Health reveals students prefer healthy school meals

FDA Advisory Committee votes in support of Pfizer's Prevnar 13

FDA: Plavix-Prilosec combination may reduce anti-clotting effect

FDA issues complete response for Rituxan, a drug for treating chronic lymphocytic leukemia

Understanding cultivated meat and its global potential eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News